NK cells and immune "memory"

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 1891-1897

  Sun, Joseph C ^a   Lopez Verges, Sandra ^b   Kim, Charles C ^b   DeRisi, Joseph L ^b   Lanier, Lewis L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD27 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; HERMES ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 7 RECEPTOR; L SELECTIN; LEUKOSIALIN;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL POPULATION; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SHORT SURVEY;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; MICE; T-LYMPHOCYTES;

EID: 79951834889     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003035     Document Type: Short Survey

References (88)

1. Kurtz, J. 2005. Specific memory within innate immune systems. Trends Immunol. 26: 186-192. (Pubitemid 41556855)
2. Little, T. J., and A. R. Kraaijeveld. 2004. Ecological and evolutionary implications of immunological priming in invertebrates. Trends Ecol. Evol. (Amst.) 19: 58-60.
3. Schmid-Hempel, P. 2005. Natural insect host-parasite systems show immune priming and specificity: puzzles to be solved. Bioessays 27: 1026-1034. (Pubitemid 41608959)
4. Kurtz, J., and K. Franz. 2003. Innate defence: evidence for memory in invertebrate immunity. Nature 425: 37-38. (Pubitemid 37101708)
5. Pham, L. N., M. S. Dionne, M. Shirasu-Hiza, and D. S. Schneider. 2007. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog. 3: e26.
6. Roth, O., B. M. Sadd, P. Schmid-Hempel, and J. Kurtz. 2009. Strain-specific priming of resistance in the red flour beetle, Tribolium castaneum. Proc. Biol. Sci. 276: 145-151.
7. Rodrigues, J., F. A. Brayner, L. C. Alves, R. Dixit, and C. Barillas-Mury. 2010. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329: 1353-1355.
8. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
9. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5: 996-1002.
10. Sun, J. C., and L. L. Lanier. 2009. Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur. J. Immunol. 39: 2059-2064.
11. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672. (Pubitemid 27513657)
12. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
13. Sun, J. C., and L. L. Lanier. 2008. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205: 1819-1828.
14. Tripathy, S. K., P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205: 1829-1841.
15. Johansson, S., M. Johansson, E. Rosmaraki, G. Vahlne, R. Mehr, M. Salmon-Divon, F. Lemonnier, K. Kärre, and P. Höglund. 2005. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J. Exp. Med. 201: 1145-1155.
16. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
17. Fernandez, N. C., E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
18. Williams, M. A., and M. J. Bevan. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25: 171-192.
19. Yokoyama, W. M., S. Kim, and A. R. French. 2004. The dynamic life of natural killer cells. Annu. Rev. Immunol. 22: 405-429.
20. Li, P., S. Burke, J. Wang, X. Chen, M. Ortiz, S. C. Lee, D. Lu, L. Campos, D. Goulding, B. L. Ng, et al. 2010. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329: 85-89.
21. Li, L., M. Leid, and E. V. Rothenberg. 2010. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329: 89-93.
22. Ikawa, T., S. Hirose, K. Masuda, K. Kakugawa, R. Satoh, A. Shibano-Satoh, R. Kominami, Y. Katsura, and H. Kawamoto. 2010. An essential developmental checkpoint for production of the T cell lineage. Science 329: 93-96.
23. Cudkowicz, G., and J. H. Stimpfling. 1964. Induction of Immunity and of Unresponsiveness to Parental Marrow Grafts in Adult F-1 Hybrid Mice. Nature 204: 450-453.
24. Gidlund, M., A. Orn, H. Wigzell, A. Senik, and I. Gresser. 1978. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273: 759-761. (Pubitemid 8357090)
25. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180: 1395-1403.
26. Greenberg, A. H., L. Hudson, L. Shen, and I. M. Roitt. 1973. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell. Nat. New Biol. 242: 111-113.
27. Herberman, R. B., M. E. Nunn, H. T. Holden, and D. H. Lavrin. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 16: 230-239.
28. Kiessling, R., E. Klein, and H. Wigzell. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5: 112-117.
29. Sendo, F., T. Aoki, E. A. Boyse, and C. K. Buafo. 1975. Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells. J. Natl. Cancer Inst. 55: 603-609.
30. Zarling, J. M., R. C. Nowinski, and F. H. Bach. 1975. Lysis of leukemia cells by spleen cells of normal mice. Proc. Natl. Acad. Sci. USA 72: 2780-2784.
31. Glas, R., L. Franksson, C. Une, M. L. Eloranta, C. Ohlén, A. Orn, and K. Kärre. 2000. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J. Exp. Med. 191: 129-138.
32. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T celland B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
33. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
34. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
35. Dokun, A. O., S. Kim, H. R. Smith, H. S. Kang, D. T. Chu, and W. M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2: 951-956.
36. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
37. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2010. Immune memory redefined: characterizing the longevity of natural killer cells. Immunol. Rev. 236: 83-94.
38. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
39. Jamieson, A. M., P. Isnard, J. R. Dorfman, M. C. Coles, and D. H. Raulet. 2004. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172: 864-870.
40. Prlic, M., B. R. Blazar, M. A. Farrar, and S. C. Jameson. 2003. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197: 967-976.
41. Koka, R., P. R. Burkett, M. Chien, S. Chai, F. Chan, J. P. Lodolce, D. L. Boone, and A. Ma. 2003. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J. Exp. Med. 197: 977-984.
42. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
43. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
44. Wherry, E. J., S. J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
45. Rutishauser, R. L., and S. M. Kaech. 2010. Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation. Immunol. Rev. 235: 219-233.
46. Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrançois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417. (Pubitemid 32231804)
47. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
48. Wherry, E. J., V. Teichgräber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
49. Badovinac, V. P., B. B. Porter, and J. T. Harty. 2002. Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 3: 619-626.
50. Homann, D., L. Teyton, and M. B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7: 913-919.
51. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
52. Etzioni, A., C. Eidenschenk, R. Katz, R. Beck, J. L. Casanova, and S. Pollack. 2005. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146: 423-425. (Pubitemid 40341757)
53. Orange, J. S. 2006. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6: 399-409.
54. Sun, J. C., and L. L. Lanier. 2009. The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors. Viruses 1: 362.
55. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671. (Pubitemid 39564443)
56. Gumá, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. López-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.
57. Mela, C. M., and M. R. Goodier. 2007. The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J. Infect. Dis. 195: 158-159, author reply 159-160.
58. Petersen, L., A. S. Roug, A. Skovbo, A. H. Thysen, C. W. Eskelund, and M. E. Hokland. 2009. The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus. Viral Immunol. 22: 333-337.
59. Monsiváis-Urenda, A., D. Noyola-Cherpitel, A. Hernández- Salinas, C. García-Sepúlveda, N. Romo, L. Baranda, M. López-Botet, and R. González-Amaro. 2010. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 40: 1418-1427.
60. Gumá, M., M. Budt, A. Sáez, T. Brckalo, H. Hengel, A. Angulo, and M. López-Botet. 2006. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107: 3624-3631.
61. Kuijpers, T. W., P. A. Baars, C. Dantin, M. van den Burg, R. A. van Lier, and E. Roosnek. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
62. Smith, K. M., J. Wu, A. B. Bakker, J. H. Phillips, and L. L. Lanier. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161: 7-10.
63. Lanier, L. L., B. Corliss, J. Wu, and J. H. Phillips. 1998. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8: 693-701.
64. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
65. Kaiser, B. K., J. C. Pizarro, J. Kerns, and R. K. Strong. 2008. Structural basis for NKG2A/CD94 recognition of HLA-E. Proc. Natl. Acad. Sci. USA 105: 6696-6701.
66. Leong, C. C., T. L. Chapman, P. J. Bjorkman, D. Formankova, E. S. Mocarski, J. H. Phillips, and L. L. Lanier. 1998. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187: 1681-1687.
67. Lanier, L. L., R. Testi, J. Bindl, and J. H. Phillips. 1989. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169: 2233-2238.
68. Caligiuri, M. A., C. Murray, H. Levine, J. A. Longtine, and J. Ritz. 1989. Clonal evidence for the induction of NKH1 on activated human thymocytes. Functional changes associated with antigen expression. Eur. J. Immunol. 19: 1735-1739.
69. Lanier, L. L., A. M. Le, C. I. Civin, M. R. Loken, and J. H. Phillips. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136: 4480-4486.
70. Lanier, L. L., A. M. Le, J. H. Phillips, N. L. Warner, and G. F. Babcock. 1983. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131: 1789-1796.
71. Abo, T., C. A. Miller, and C. M. Balch. 1984. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults. Eur. J. Immunol. 14: 616-623.
72. Tilden, A. B., C. E. Grossi, K. Itoh, G. A. Cloud, P. A. Dougherty, and C. M. Balch. 1986. Subpopulation analysis of human granular lymphocytes: associations with age, gender and cytotoxic activity. Natural Immunity and Cell Growth Regulation 5: 90-99.
73. Merino, J., M. A. Martínez-González, M. Rubio, S. Inogés, A. Sánchez-Ibarrola, and M. L. Subirá. 1998. Progressive decrease of CD8high+ CD28+ CD57- cells with ageing. Clin. Exp. Immunol. 112: 48-51.
74. Chattopadhyay, P. K., M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa. 2009. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J. Leukoc. Biol. 85: 88-97.
75. Lopez-Verges, S., J. M. Milush, S. Pandey, V. A. York, J. Arakawa-Hoyt, H. Pircher, P. J. Norris, D. F. Nixon, and L. L. Lanier. 2010. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK cell subset. Blood 116: 3865-3874.
76. Bjorkstrom, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Bjorklund, M. Flodstrom-Tullberg, J. Michaelsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK cell differentiation uncoupled from NK cell education. Blood 116: 3853-3864.
77. Béziat, V., B. Descours, C. Parizot, P. Debré, and V. Vieillard. 2010. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5: e11966.
78. Le Priol, Y., D. Puthier, C. Lécureuil, C. Combadière, P. Debré, C. Nguyen, and B. Combadière. 2006. High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J. Immunol. 177: 5145-5154. (Pubitemid 44527586)
79. Monteiro, J., F. Batliwalla, H. Ostrer, and P. K. Gregersen. 1996. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156: 3587-3590.
80. Middleton, D., and F. Gonzelez. 2010. The extensive polymorphism of KIR genes. Immunology 129: 8-19.
81. McQueen, K. L., and P. Parham. 2002. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14: 615-621.
82. Bashirova, A. A., M. P. Martin, D. W. McVicar, and M. Carrington. 2006. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7: 277-300.
83. Fisher, R. A. 2009. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl. Infect. Dis. 11: 195-202.
84. Reeves, M., and J. Sinclair. 2008. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325: 297-313.
85. Britt, W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325: 417-470.
86. Moretta, A., F. Locatelli, and L. Moretta. 2008. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol. Rev. 224: 58-69.
87. Vitale, M., M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta. 2004. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur. J. Immunol. 34: 1715-1722.
88. Kim, C. C., S. Parikh, J. C. Sun, A. Myrick, L. L. Lanier, P. J. Rosenthal, and J. L. DeRisi. 2008. Experimental malaria infection triggers early expansion of natural killer cells. Infect. Immun. 76: 5873-5882.